Are cerebrovascular factors involved in Alzheimer's disease?

被引:64
|
作者
Kudo, T
Imaizumi, K
Tanimukai, H
Katayama, T
Sato, N
Nakamura, Y
Tanaka, T
Kashiwagi, Y
Jinno, Y
Tohyama, M
Takeda, M
机构
[1] Osaka Univ, Grad Sch Med, Dept Clin Neurosci Psychiat, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan
[3] Tanabe Seiyaku Co Ltd, Yodogawa Ku, Osaka 5320031, Japan
关键词
Alzheimer's disease; cerebrovascular disorder; vascular dementia; risk factor; presenilin;
D O I
10.1016/S0197-4580(00)00129-9
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Recent epidemiological studies have shown that vascular risk factors may be involved in Alzheimer's disease (AD) as well as dementia in general. To investigate the relation between a vascular disorder and AD pathology, current criteria are defective because most depend on exclusion of a cerebrovascular disorder. Epidemiological studies have indicated the possibilities that arteriosclerosis, abnormal blood pressure, diabetes mellitus and smoking may be related to the pathogenesis of AD. As for the mechanism that vascular disorders influence AD, it is presumed that amyloid deposition may be caused by a vascular disorder. Alternatively, a vascular event may cause progression of subclinical AD to a clinical stage. Insulin resistance and apolipoprotein E may also be involved in these mechanisms. Our studies show that ischemia-induced the Alzheimer-associated gene presenilin 1 (PS1) and endoplasmic reticulum-stress, generated from a vascular disorder, may unmask clinical AD symptoms caused by presenilin mutation, suggesting that a vascular factor might be involved in the onset of familial AD. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:215 / 224
页数:10
相关论文
共 50 条
  • [21] Cerebrovascular disease promotes tau pathology in Alzheimer's disease
    Laing, Krystal K.
    Simoes, Sabrina
    Baena-Caldas, Gloria P.
    Lao, Patrick J.
    Kothiya, Milankumar
    Igwe, Kay C.
    Chesebro, Anthony G.
    Houck, Alexander L.
    Pedraza, Lina
    Hernandez, A. Ivan
    Li, Jie
    Zimmerman, Molly E.
    Luchsinger, Jose A.
    Barone, Frank C.
    Moreno, Herman
    Brickman, Adam M.
    BRAIN COMMUNICATIONS, 2020, 2 (02)
  • [22] Alzheimer's disease with cerebrovascular disease: current status in the Asia-Pacific region
    Chen, C.
    Homma, A.
    Mok, V. C. T.
    Krishnamoorthy, E.
    Alladi, S.
    Meguro, K.
    Abe, K.
    Dominguez, J.
    Marasigan, S.
    Kandiah, N.
    Kim, S. Y.
    Lee, D. Y.
    De Silva, H. A.
    Yang, Y. -H.
    Pai, M. -C.
    Senanarong, V.
    Dash, A.
    JOURNAL OF INTERNAL MEDICINE, 2016, 280 (04) : 359 - 374
  • [23] Is dopamine involved in Alzheimer's disease?
    Martorana, Alessandro
    Koch, Giacomo
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [24] Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease
    Reed, Bruce R.
    Mungas, Dan M.
    Kramer, Joel H.
    Ellis, William
    Vinters, Harry V.
    Zarow, Chris
    Jagust, William J.
    Chui, Helena C.
    BRAIN, 2007, 130 : 731 - 739
  • [25] Relevant clinical outcomes in probable vascular dementia and Alzheimer's disease with cerebrovascular disease
    O'Brien, J
    Lilienfeld, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 203 : 41 - 48
  • [26] Cerebrovascular phenotypes in mouse models of Alzheimer's disease
    Szu, Jenny, I
    Obenaus, Andre
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (08) : 1821 - 1841
  • [27] Metabolic syndrome and cerebrovascular impairment in Alzheimer's disease
    Viticchi, Giovanna
    Falsetti, Lorenzo
    Buratti, Laura
    Luzzi, Simona
    Bartolini, Marco
    Acciarri, Maria Cristina
    Provinciali, Leandro
    Silvestrini, Mauro
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 30 (12) : 1164 - 1170
  • [28] Cerebrovascular insulin receptors are defective in Alzheimer's disease
    Leclerc, Manon
    Bourassa, Philippe
    Tremblay, Cyntia
    Caron, Vicky
    Sugere, Camille
    Emond, Vincent
    Bennett, David A.
    Calon, Frederic
    BRAIN, 2023, 146 (01) : 75 - 90
  • [29] Cerebrovascular Assessment for the Risk Prediction of Alzheimer's Disease
    Silvestrini, Mauro
    Viticchi, Giovanna
    Altamura, Claudia
    Luzzi, Simona
    Balucani, Clotilde
    Vernieri, Fabrizio
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 32 (03) : 689 - 698
  • [30] Bivalent Ligands Targeting Multiple Pathological Factors Involved in Alzheimer's Disease
    Liu, Kai
    Gandhi, Ronak
    Chen, Jiangmin
    Zhang, Shijun
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (11): : 942 - 946